Loading...
MISX
APTK
Market cap1.06bUSD
Mar 04, Last price  
11.72RUB
1D
1.17%
1Q
17.01%
Jan 2017
13.71%
IPO
-96.03%
Name

Aptechnaya Set' 36,6 PAO

Chart & Performance

D1W1MN
No data to show
P/E
401.16
P/S
1.52
EPS
0.03
Div Yield, %
—
Shrs. gr., 5y
23.69%
Rev. gr., 5y
4.12%
Revenues
59.05b
+33.88%
20,765,084,45930,718,248,44821,061,500,00020,381,100,00021,594,000,00020,923,000,00011,911,000,00019,071,000,00031,890,000,00045,947,000,00048,253,000,00044,664,000,00046,049,000,00039,267,000,00044,104,000,00059,048,000,000
Net income
223m
P
00-359,400,000-929,600,000-1,034,000,000-971,000,000-10,400,000,000-115,000,000-178,000,000-9,345,000,000-13,097,000,000-22,977,000,000-8,855,000,000-992,000,000-950,000,000223,000,000
CFO
6.60b
+104.37%
0378,612,362-2,377,000,000-1,929,000,000-1,000,000809,000,000-3,628,000,000-356,000,0003,806,000,000-3,483,000,000-11,134,000,000-9,196,000,000-1,785,000,000-3,366,000,0003,227,000,0006,595,000,000
Earnings
Aug 25, 2025

Profile

Public Joint-Stock Company Pharmacy Chain 36.6 operates pharmacies in Russia. Its pharmacies offer health and beauty products. The company serves customers under the 36.6, Romir, and Gorzdrav brands. Public Joint-Stock Company Pharmacy Chain 36.6 was founded in 1991 and is based in Moscow, Russia.
URL
https://pharmacychain366.ru/
IPO date
Jan 20, 2005
Employees
Domiciled in
RU
Incorporated in
RU

Valuation

Title
RUB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
59,048,000
33.88%
Cost of revenue
40,285,000
Unusual Expense (Income)
NOPBT
18,763,000
NOPBT Margin
31.78%
Operating Taxes
188,000
Tax Rate
1.00%
NOPAT
18,575,000
Net income
223,000
-123.47%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
10,281,000
Long-term debt
35,703,000
Deferred revenue
(347,000)
Other long-term liabilities
347,000
Net debt
45,853,000
Cash flow
Cash from operating activities
6,595,000
CAPEX
(1,035,000)
Cash from investing activities
(995,000)
Cash from financing activities
(6,516,000)
FCF
17,298,000
Balance
Cash
811,000
Long term investments
(680,000)
Excess cash
Stockholders' equity
(51,012,000)
Invested Capital
76,127,000
ROIC
24.58%
ROCE
73.69%
EV
Common stock shares outstanding
7,630,434
Price
11.57
-16.76%
Market cap
88,284,119
-16.76%
EV
134,137,119
EBITDA
24,552,000
EV/EBITDA
5.46
Interest
4,241,000
Interest/NOPBT
22.60%